NASDAQ · HUM
Healthcare · Medical - Healthcare Plans
$431.87
Up+$43.91 (+11.34%)
Updated Oct 10, 2026, 9:01 PM
SID Score
7.3/10
Composite research score
Smart Money
62/100
Neutral
Price performance · HUM
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
HUM closed at $431.87 after 21 trading sessions, up 5.39% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $450.49 | $456.50 | $428.4461 | $431.87 | 4.99M |
| Oct 8, 2026 | $396.03 | $399.19 | $375.86 | $387.12 | 2.68M |
| Oct 7, 2026 | $410.00 | $410.01 | $394.81 | $396.51 | 1.83M |
| Oct 6, 2026 | $405.02 | $408.04 | $396.04 | $404.27 | 1.98M |
| Oct 5, 2026 | $389.98 | $409.17 | $385.20 | $404.07 | 1.52M |
| Oct 2, 2026 | $378.54 | $390.00 | $378.50 | $388.36 | 765.06K |
| Oct 1, 2026 | $380.00 | $386.86 | $376.225 | $379.68 | 891.93K |
| Sep 30, 2026 | $385.54 | $391.325 | $378.50 | $381.57 | 1.31M |
| Sep 29, 2026 | $386.78 | $395.23 | $385.54 | $386.87 | 1.89M |
| Sep 28, 2026 | $397.43 | $408.19 | $389.10 | $389.63 | 1.49M |
| Sep 25, 2026 | $389.70 | $413.57 | $386.7072 | $397.93 | 1.94M |
| Sep 24, 2026 | $374.54 | $382.30 | $372.08 | $380.32 | 899.02K |
| Sep 23, 2026 | $370.00 | $377.68 | $369.1322 | $374.78 | 798.64K |
| Sep 22, 2026 | $378.42 | $379.91 | $370.00 | $372.00 | 858.14K |
| Sep 21, 2026 | $386.20 | $386.67 | $374.345 | $378.58 | 925.97K |
| Sep 18, 2026 | $384.81 | $386.22 | $380.04 | $386.22 | 1.68M |
| Sep 17, 2026 | $386.62 | $387.83 | $380.41 | $384.52 | 850.2K |
| Sep 16, 2026 | $396.41 | $396.52 | $382.92 | $384.72 | 1.04M |
| Sep 15, 2026 | $405.29 | $405.29 | $393.56 | $396.62 | 852.1K |
| Sep 14, 2026 | $409.01 | $415.77 | $406.89 | $407.02 | 708.89K |
| Sep 11, 2026 | $404.76 | $410.985 | $401.17 | $409.80 | 684.06K |
The latest Smart Investors Daily articles mentioning HUM.
Company
Market Activity
Research & News
HUM research
Company profile and research snapshot.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 9, 2026 | Barclays | Overweight | — |
| Oct 9, 2026 | Oppenheimer | Outperform | — |
| Oct 9, 2026 | Baird | Outperform | — |
| Oct 7, 2026 | Cantor Fitzgerald | Overweight | — |
| Sep 25, 2026 | Barclays | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 1, 2026
Humana already told investors in July how many members it plans to drop. What your neighbor with a surviving plan has not figured out yet is how quietly the costs on that plan changed before open enrollment closes Dec. 7.
Yahoo · Oct 1, 2026
LOUISVILLE, Ky., October 01, 2026--As Medicare’s Annual Election Period (AEP) begins Oct. 15, Humana is offering 2027 Medicare Advantage plans designed to deliver high-value coverage with affordable monthly premiums. Members will have continued access to the benefits they value most – including $0 cost-sharing on in-network primary care visits and labs plus dental, vision, and hearing coverage. Additional 2027 highlights include:
Benzinga · Oct 1, 2026
Additional 2027 highlights include:Medicare Advantage plans in approximately 2,600 counties across 45 states and Washington, D.C., representing more than 80% of U.S. counties.Expanded Chronic Condition Special Needs
Yahoo · Sep 29, 2026
What a time it’s been for Humana. In the past six months alone, the company’s stock price has increased by a massive 136%, reaching $391.06 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HUM.
